Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardinal, McKesson need to seed 20+ competing facilities for FTC approval -- attorney.

This article was originally published in The Tan Sheet

Executive Summary

FTC WANTS CARDINAL, McKESSON TO SUPPORT MORE THAN 20 COMPETITIVE SITES, with Cardinal Health offering to fund competing distribution centers in four western regions. The offer by Cardinal is an attempt to reach agreement with the Federal Trade Commission to allow the wholesaler to merge with Bergen Brunswig, Cardinal attorney Bernard Nussbaum (Wachtell, Lipton, Rosen & Katz, New York City) said during closing arguments July 24 in the wholesaler merger antitrust suit in D.C. federal court. Federal Judge Stanley Sporkin previously had suggested July 14 that FTC and the wholesalers attempt to reach an agreement in which the merged entities could provide "seed" money to help regional wholesalers expand into areas left with a lack of competition in the post-merger market.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088714

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel